Ultrasound-Mediated Delivery of Nanopharmaceuticals
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 21406
Special Issue Editors
Interests: targeted drug delivery using ultrasound; microbubble dynamics in ultrasound therapy; ultrasound therapy monitoring
Interests: focused ultrasound; drug delivery; blood-brain barrier; brain disorders; microbubbles
Special Issue Information
Dear Colleagues,
A whole class of nanopharmaceuticals such as theranostic nanoparticles, liposomes, monoclonal antibodies, and viral vectors, are not able to effectively reach their targets due to the presence of biological barriers. Ultrasound-mediated drug delivery shows great potential in overcoming the blood–brain or blood–tumor barrier, enabling non-invasive and localized increase of the delivered dose, thereby enlarging the therapeutic window.
In this Special Issue, we invite contributions focused on both preclinical and clinical research on ultrasound-mediated delivery of nanopharmaceuticals. We also welcome numerical and experimental work on ultrasound- or heat-responsive theranostic agents, designed for concurrent imaging and therapy of neurodegenerative diseases, cancer, etc. Potential applications include but are not limited to targeted immunotherapies, neuromodulation, neurorestoration and neuroprotection, chemotherapeutic delivery, tumor tagging, and targeted micro-/nanobubbles.
Submitted manuscripts should highlight the translational potential of ultrasound-mediated drug delivery and should be within the wider scope of Pharmaceutics.
Dr. Antonios N. Pouliopoulos
Dr. Sophie V. Morse
Dr. Natasha D. Sheybani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- therapeutic ultrasound
- nanomedicine
- biological barriers
- targeted drug delivery
- theranostics
- immunotherapy
- micro-/nanobubbles
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.